Lacrofarm Junior (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Sodium hydrogen carbonate acts as a systemic buffer, while potassium chloride and sodium chloride replenish essential electrolytes. Macrogol 3350 is a non‑absorbable polymer that draws water into the intestinal lumen by osmotic pressure, softening stools and promoting bowel movements.

The dose of Lacrofarm Junior is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and response to therapy. No fixed dosing regimen is provided here.

Safety of Lacrofarm Junior in pregnancy or lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk, and this decision must be made by a qualified healthcare provider.

To order Lacrofarm Junior, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Lacrofarm Junior combines electrolyte replacement with an osmotic laxative, whereas many pediatric laxatives contain only the laxative component. This dual action can be advantageous when both bowel regularity and electrolyte support are needed, but the choice depends on the specific clinical scenario and physician preference.

Lacrofarm Junior should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain stability.

Lacrofarm Junior is taken orally. The exact method of administration—such as mixing with a specified volume of water or directly swallowing—should follow the instructions provided by the prescribing clinician.

The most serious risks include severe electrolyte imbalance (such as hyperkalemia or hyponatremia), allergic reactions, and, in rare cases, intestinal obstruction or acute renal impairment. Patients should be monitored for these events, especially during prolonged use.

Lacrofarm Junior should be avoided in individuals with known hypersensitivity to any of its ingredients, in patients with severe renal impairment without medical supervision, and in those who are already receiving high doses of potassium or sodium-containing therapies unless directed by a healthcare professional.